Our study "Global Pharmaceutical Market Forecast to 2012" reveals that after having experienced exponential growth during the past few years, pharmaceutical market is now witnessing a slump in key pharma markets such as, the US and Western Europe. Meanwhile, pharma markets in some developing regions like the Asia-Pacific has been continuously witnessing robust growth rate for the last few years on account of increasing prevalence of diseases, rising healthcare spending, and increasing affordability. We have found that the Asia-Pacific region is a key pharmaceutical market, with Japan being the second largest pharmaceutical market globally after the US. Many countries are emerging as lucrative markets worldwide. Furthermore, the market is projected to grow at a CAGR of nearly 12% by 2012.
Despite facing challenges, pharmaceutical market has an array of opportunities. Economies of emerging markets, such as India, China, Brazil, Russia, Turkey, Mexico, and Vietnam, are booming, and so is their healthcare spending. Majority of the drug manufacturers had earlier ignored these markets due to their low pharmaceutical spending and questionable intellectual property protection. But today, irrespective of their IPR protection, drug manufacturers are keen to launch their innovative products in these markets.
There has been a rapid shift of manufacturers to niche therapy areas and highly profitable biopharmaceuticals and vaccines from traditional therapies and small molecules. Our report has assessed the geographical performance, leading therapy classes, leading drugs, and leading pharmaceutical companies. Our report has also covered the key player's profiles along with their strengths and weaknesses.
Our report provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific, and Africa have been selected as the most important regions to be presented in this report. The report contains statistical and analytical information on each of these markets, covering their current market size, demand, and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.
For more information visit: http://www.rncos.com/Report/IM149.htm |